Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kluth

Showing results (581-590 of 1,145) with videos related to

Pageof 115
Sort By:
Plos One|June 2, 2015
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate CancersChristoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, et al.
World Journal of Urology|October 26, 2022
Learning curve and functional outcomes after laser enucleation of the prostate for benign prostate hyperplasia according to surgeon's caseloadM Kosiba, B Hoeh, M N Welte, et al.
Medicina (Kaunas, Lithuania)|June 28, 2023
Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical ProstatectomyCristina Cano Garcia, Mike Wenzel, Clara Humke, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2021
Sex- and Age-Related Differences in the Distribution of Metastases in Patients With Upper Urinary Tract Urothelial CarcinomaMarina Deuker, Giuseppe Rosiello, Lara Franziska Stolzenbach, et al.
Oncoimmunology|July 30, 2016
Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiotaNatali Pflug, Sandra Kluth, Jörg J Vehreschild, et al.
Molecular and Clinical Oncology|August 31, 2021
High mitochondrial content is associated with breast cancer aggressivenessPatrick Lebok, Katharina Schütt, Martina Kluth, et al.
European Urology|September 4, 2013
Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladderMalte Rieken, Evanguelos Xylinas, Luis Kluth, et al.
International Journal of Cancer|May 27, 2015
Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancerMartina Kluth, Frederic Runte, Philipp Barow, et al.
Prostate Cancer and Prostatic Diseases|September 2, 2018
Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancerMarieke J Krimphove, Alexander P Cole, Sean A Fletcher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2013
Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusionsMartina Kluth, Jana Hesse, Anna Heinl, et al.
Pageof 115

Showing results (581-590 of 1,145) with videos related to

Sort By:
Pageof 115
Plos One|June 2, 2015
Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate CancersChristoph Burdelski, Erzen Bujupi, Maria Christina Tsourlakis, et al.
World Journal of Urology|October 26, 2022
Learning curve and functional outcomes after laser enucleation of the prostate for benign prostate hyperplasia according to surgeon's caseloadM Kosiba, B Hoeh, M N Welte, et al.
Medicina (Kaunas, Lithuania)|June 28, 2023
Impact of Age on Long-Term Urinary Continence after Robotic-Assisted Radical ProstatectomyCristina Cano Garcia, Mike Wenzel, Clara Humke, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2021
Sex- and Age-Related Differences in the Distribution of Metastases in Patients With Upper Urinary Tract Urothelial CarcinomaMarina Deuker, Giuseppe Rosiello, Lara Franziska Stolzenbach, et al.
Oncoimmunology|July 30, 2016
Efficacy of antineoplastic treatment is associated with the use of antibiotics that modulate intestinal microbiotaNatali Pflug, Sandra Kluth, Jörg J Vehreschild, et al.
Molecular and Clinical Oncology|August 31, 2021
High mitochondrial content is associated with breast cancer aggressivenessPatrick Lebok, Katharina Schütt, Martina Kluth, et al.
European Urology|September 4, 2013
Long-term cancer-specific outcomes of TaG1 urothelial carcinoma of the bladderMalte Rieken, Evanguelos Xylinas, Luis Kluth, et al.
International Journal of Cancer|May 27, 2015
Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancerMartina Kluth, Frederic Runte, Philipp Barow, et al.
Prostate Cancer and Prostatic Diseases|September 2, 2018
Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancerMarieke J Krimphove, Alexander P Cole, Sean A Fletcher, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 2, 2013
Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusionsMartina Kluth, Jana Hesse, Anna Heinl, et al.
Pageof 115